Science Explorer Back to mapMap
Discussion
Company · Gaithersburg · United States

Altimmune (United States)

altimmune.comROR OpenAlex
World rank, all time
#19,280
of 34,923
Rank in United States
#4,005
of 7,310
Research works
219
▼ 87% vs 2018-21
Citations
12k
55.8 per fractional work
Top-10% rate
28.5%
all institutions 10.0%
vs its own fields
1.15×
1.00× is exactly expected
Open access
40%
world 40%
International
21%
world 18%
Altimmune (United States)

Which fields of science does Altimmune (United States) work in?

In all years, 48% of research at Altimmune (United States) is in Health Sciences, 41% in Life Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (12%). It does 2.6× the world's share of Life Sciences.

Health Sciences: 105 fractional works · 47.8% of its workMedicine: 101 fractional works · 46.2% of its workEpidemiology: 20 fractional works · 9.1% of its workRadiology, Nuclear Medicine and Imaging: 20 fractional works · 9.0% of its workOncology: 14 fractional works · 6.6% of its workPulmonary and Respiratory Medicine: 9 fractional works · 3.9% of its workPhysiology: 6 fractional works · 2.8% of its workRheumatology: 6 fractional works · 2.7% of its workInfectious Diseases: 5 fractional works · 2.5% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 1.4% of its workPathology and Forensic Medicine: 2 fractional works · 1.1% of its workSurgery: 2 fractional works · 0.8% of its workHematology: 2 fractional works · 0.8% of its workImmunology and Allergy: 2 fractional works · 0.7% of its workPharmacology: 1 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.6% of its workGenetics: 1 fractional works · 0.4% of its workHepatology: 1 fractional works · 0.4% of its workPsychiatry and Mental health: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.3% of its workEmergency Medicine: 1 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 1.1% of its workHealth Professions: 3 fractional works · 1.2% of its workEmergency Medical Services: 1 fractional works · 0.6% of its workMedical Laboratory Technology: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.4% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 89 fractional works · 40.8% of its workBiochemistry, Genetics and Molecular Biology: 54 fractional works · 24.6% of its workMolecular Biology: 42 fractional works · 19.2% of its workCancer Research: 3 fractional works · 1.5% of its workGenetics: 2 fractional works · 1.0% of its workBiotechnology: 2 fractional works · 0.9% of its workEndocrinology: 1 fractional works · 0.6% of its workCell Biology: 1 fractional works · 0.3% of its workMolecular Medicine: 1 fractional works · 0.3% of its workPhysiology: 1 fractional works · 0.2% of its workClinical Biochemistry: 1 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workImmunology and Microbiology: 25 fractional works · 11.6% of its workImmunology: 23 fractional works · 10.5% of its workMicrobiology: 2 fractional works · 0.7% of its workSmaller subfields together: 1 fractional works · 0.4% of its workAgricultural and Biological Sciences: 5 fractional works · 2.3% of its workFood Science: 3 fractional works · 1.2% of its workAgronomy and Crop Science: 1 fractional works · 0.5% of its workAnimal Science and Zoology: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 1.2% of its workPharmaceutical Science: 1 fractional works · 0.6% of its workPharmacology: 1 fractional works · 0.3% of its workToxicology: 1 fractional works · 0.2% of its workNeuroscience: 3 fractional works · 1.2% of its workCellular and Molecular Neuroscience: 2 fractional works · 0.8% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPhysical Sciences: 20 fractional works · 9.1% of its workEngineering: 7 fractional works · 3.0% of its workBiomedical Engineering: 5 fractional works · 2.3% of its workMechanics of Materials: 1 fractional works · 0.3% of its workComputational Mechanics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workMathematics: 5 fractional works · 2.4% of its workStatistics and Probability: 5 fractional works · 2.2% of its workModeling and Simulation: 0 fractional works · 0.2% of its workChemistry: 3 fractional works · 1.6% of its workSpectroscopy: 2 fractional works · 0.9% of its workOrganic Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workMaterials Science: 2 fractional works · 0.8% of its workMaterials Chemistry: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workPhysics and Astronomy: 1 fractional works · 0.5% of its workRadiation: 1 fractional works · 0.5% of its workComputer Science: 1 fractional works · 0.5% of its workComputational Theory and Mathematics: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workEnvironmental Science: 1 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workChemical Engineering: 0 fractional works · 0.1% of its workSocial Sciences: 5 fractional works · 2.3% of its workDecision Sciences: 2 fractional works · 1.0% of its workStatistics, Probability and Uncertainty: 1 fractional works · 0.7% of its workManagement Science and Operations Research: 1 fractional works · 0.4% of its workSocial Sciences: 2 fractional works · 0.7% of its workHealth: 1 fractional works · 0.4% of its workSociology and Political Science: 1 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.4% of its workEconomics and Econometrics: 1 fractional works · 0.4% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKAltimmune (UnitedStates)219fractional works, all years
Life Sciences41%Physical Sciences9%Health Sciences48%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 23 fields, with their numbers
    1. Medicine10146.2%
    2. Health Professions31.2%
    3. Nursing10.3%
    4. Veterinary00.1%
    5. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology5424.6%
    2. Immunology and Microbiology2511.6%
    3. Agricultural and Biological Sciences52.3%
    4. Pharmacology, Toxicology and Pharmaceutics31.2%
    5. Neuroscience31.2%
    1. Engineering73.0%
    2. Mathematics52.4%
    3. Chemistry31.6%
    4. Materials Science20.8%
    5. Physics and Astronomy10.5%
    6. Computer Science10.5%
    7. Environmental Science10.3%
    8. Earth and Planetary Sciences00.1%
    9. Chemical Engineering00.1%
    1. Decision Sciences21.0%
    2. Social Sciences20.7%
    3. Economics, Econometrics and Finance10.4%
    4. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.06× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.33× its world share, 0 worksImmunology and Micro…Neuroscience: 1.44× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 9.98× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.49× its world share, 0 worksChemistryComputer Science: 0.45× its world share, 0 worksComputer ScienceEngineering: 0.47× its world share, 0 worksEngineeringMedicine: 3.20× its world share, 3 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.0×. Every wedge is a field page.

All 8 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics9.98×0 works
  2. Immunology and Microbiology3.33×0 works
  3. Medicine3.20×3 works
  4. Biochemistry, Genetics and Molecular Biology3.06×1 works
  5. Chemistry1.49×0 works
  6. Neuroscience1.44×0 works
  7. Engineering0.47×0 works
  8. Computer Science0.45×0 works

Who are the top researchers at Altimmune (United States)?

Ranked on the quality score, Ronald Herbst, Stefanie Mullins and Robert E. Hollingsworth lead among researchers whose main affiliation is Altimmune (United States).

  1. 1 Ronald Herbst United States · #83,695 worldwide 12k citations · 330 works
  2. 2 Stefanie Mullins United States · #517,752 worldwide 2.6k citations · 54 works
  3. 3 Robert E. Hollingsworth United States · #546,066 worldwide 5k citations · 184 works
  4. 4 Mark A. Schenerman United States · #848,208 worldwide 2.1k citations · 40 works
  5. 5 Christine A. Fazenbaker United States · #1,667,277 worldwide 961 citations · 41 works
  6. 6 Karma Dacosta United States · #1,846,801 worldwide 423 citations · 32 works
  7. 7 Harry Yang United States · #3,752,551 worldwide 1.6k citations · 100 works
All ranked researchers at Altimmune (United States)

What are the most cited papers from Altimmune (United States)?

The most cited paper from Altimmune (United States) is "New use of BCG for recombinant vaccines" (C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al., 1991), with 1,513 citations. Next come "Targeting interleukin-6 in inflammatory autoimmune diseases and cancers" (674) and "Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus" (647).

Most cited papers
#PaperReleasedCitations
1 New use of BCG for recombinant vaccines C. Kendall Stover, Vidal F. de la Cruz, Thomas R. Fuerst et al. · Nature 6 Jun 1991 1,513
2 Targeting interleukin-6 in inflammatory autoimmune diseases and cancers Xin Yao, Jiaqi Huang, Haihong Zhong et al. · Pharmacology & Therapeutics 27 Sep 2013 674
3 Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus Syd Johnson, Cynthia N. Oliver, Gregory A. Prince et al. · The Journal of Infectious Diseases Open access Nov 1997 647
4 Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression Heng Lin, Shuang Wei, Elaine M. Hurt et al. · Journal of Clinical Investigation Open access 15 Jan 2018 610
5 CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade Limo Chen et al. · Cancer Discovery Open access 16 Jul 2018 481
All 61 most cited papers, with filters and sorting

Which keywords describe research at Altimmune (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Monoclonal Antibodies, Therapeutic Antibodies, Glycosylation, Epidemiology, Biopharmaceuticals, Immunogenicity, Antibody Engineering and Fc Receptors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Monoclonal Antibodies34▲ 108×3 topics
  2. Epidemiology32▲ 3.6×46 topics
  3. Therapeutic Antibodies31▲ 108×2 topics
  4. Glycosylation28▲ 58×3 topics
  5. Biopharmaceuticals18▲ 123×3 topics
  6. Immunogenicity18▲ 158×2 topics
  7. Inflammation17▲ 3.2×32 topics
  8. Antibody Engineering16▲ 74×1 topic
  9. Fc Receptors16▲ 74×1 topic
  10. Recombinant Proteins15▲ 128×2 topics
  11. Protein Aggregation14▲ 83×1 topic
  12. Stability14▲ 34×1 topic
  13. Monoclonal Antibody11▲ 74×2 topics
  14. Vaccine Development11▲ 17×7 topics
  15. Cancer10▲ 3.4×23 topics
  16. Cell Culture9▲ 39×2 topics
  17. Mammalian Cells9▲ 105×1 topic
  18. Recombinant Protein9▲ 105×1 topic
  19. Pathogenesis9▲ 7.3×11 topics
  20. Human Metapneumovirus8▲ 85×1 topic
  21. Respiratory Syncytial Virus8▲ 85×1 topic
  22. Treatment8▲ 2.9×18 topics
  23. Cancer Immunotherapy7▲ 24×3 topics
  24. Immunity7▲ 9.3×8 topics
  25. Tumor Microenvironment6▲ 8.3×6 topics
  26. Immune Response6▲ 4.6×15 topics
  27. Autoantibodies6▲ 12×6 topics
  28. Vaccine6▲ 6.8×9 topics
  29. Cancer Therapy6▲ 4.2×13 topics
  30. Pandemic6▲ 5.6×3 topics
  31. Innate Immunity5▲ 7.0×8 topics
  32. Respiratory5▲ 25×2 topics
  33. Antigen Presentation4▲ 20×2 topics
  34. Asthma4▲ 16×3 topics
  35. Virus4▲ 17×2 topics
  36. Antibodies4▲ 21×2 topics
  37. Dendritic Cells4▲ 17×2 topics
  38. Allergic Diseases4▲ 23×1 topic
  39. Bayesian Methods4▲ 32×2 topics
  40. Eosinophils4▲ 23×1 topic

Which research topics does Altimmune (United States) publish most on?

By volume in 2022-now: Liver Disease Diagnosis and Treatment, Viral Infectious Diseases and Gene Expression in Insects, Nanowire Synthesis and Applications and COVID-19 Clinical Research Studies.

Liver Disease Diagnosis …0Liver Disease Diagnosis and Treatment: 0 fractional worksViral Infectious Disease…0Viral Infectious Diseases and Gene Expression in Insects: 0 fractional worksNanowire Synthesis and Applications: 0 fractional worksCOVID-19 Clinical Resear…0COVID-19 Clinical Research Studies: 0 fractional worksSARS-CoV-2 and COVID-19 …0SARS-CoV-2 and COVID-19 Research: 0 fractional worksCAR-T cell therapy research: 0 fractional worksRespiratory viral infections research: 0 fractional worksLiver Disease and Transp…0Liver Disease and Transplantation: 0 fractional worksComputational Drug Discovery Methods: 0 fractional worksReceptor Mechanisms and Signaling: 0 fractional works
EpidemiologyMolecular BiologyBiomedical EngineeringInfectious Diseases3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  2. 2 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
  3. 3 Nanowire Synthesis and Applications Biomedical Engineering 0 works
  4. 4 COVID-19 Clinical Research Studies Infectious Diseases 0 works
  5. 5 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
  6. 6 CAR-T cell therapy research Oncology 0 works
  7. 7 Respiratory viral infections research Epidemiology 0 works
  8. 8 Liver Disease and Transplantation Hepatology 0 works
  9. 9 Computational Drug Discovery Methods Computational Theory and Mathematics 0 works
  10. 10 Receptor Mechanisms and Signaling Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available39.7%not open60.3%

World: 40% of research is openly available.

with international co-authors20.7%domestic only79.3%

World: 18% is written across borders.

How has Altimmune (United States)'s research output changed?

Output in 2022-2025 was 87% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Altimmune (United States) as a percentage of every work published that year, 0.0000036% in 2024.

still counting0.00025%0.00050%0.00075%Altimmune (United States)0.000021% in 2025200020102020

Fractional works of Altimmune (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Gaithersburg

All research institutions in Gaithersburg

Share Altimmune (United States)'s ranking

Altimmune (United States) on Science Explorer

A card with Altimmune (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Altimmune (United States). Posts are plain text and can be reported.